Patent details

Basic Information

Publication number:

EP3419622

PCT Application Number:

US2017019266

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177572617

PCT Publication Number:

WO2017147366

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF NEURODEGENERATIVE EYE DISEASE USING PRIDOPIDINE

French Title of Invention:

TRAITEMENT D'UNE MALADIE NEURODÉGÉNÉRATIVE DE L'OEIL À L'AIDE DE PRIDOPIDINE

German Title of Invention:

BEHANDLUNG VON NEURODEGENERATIVEN AUGENERKRANKUNGEN MIT PRIDOPIDIN

SPC Number:

Dates

Filing date:

24/02/2017

Grant date:

06/03/2024

EP Publication Date:

02/01/2019

PCT Publication Date:

31/08/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/03/2024

EP B1 Publication Date:

06/03/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/02/2025

Expiration date:

24/02/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/02/2024

 

 

Name:

Prilenia Neurotherapeutics Ltd.

Address:

10 HaMenofim Street, Herzliya 4672561, Israel (IL)

Inventor

1

Name:

RUSS, Hermann, Kurt

Address:

Switzerland (CH)

2

Name:

LAUFER, Ralph

Address:

Israel (IL)

3

Name:

ORBACH, Aric

Address:

Israel (IL)

4

Name:

GEVA, Michal

Address:

Israel (IL)

Priority

Priority Number:

201662299290 P

Priority Date:

24/02/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/451; A61K 31/4704;

Publication

European Patent Bulletin

Issue number:

202410

Publication date:

06/03/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages